CATALOGO DEI PRODOTTI DELLA RICERCA

BELLINATO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.970
NA - Nord America 3.770
AS - Asia 3.013
SA - Sud America 503
AF - Africa 199
OC - Oceania 47
Totale 11.502
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.655
RU - Federazione Russa 1.764
SG - Singapore 1.371
IT - Italia 867
CN - Cina 498
BR - Brasile 400
HK - Hong Kong 298
VN - Vietnam 269
DE - Germania 241
GB - Regno Unito 221
IE - Irlanda 163
FI - Finlandia 145
SE - Svezia 140
FR - Francia 116
KR - Corea 98
NL - Olanda 79
BD - Bangladesh 75
IN - India 75
ID - Indonesia 68
TR - Turchia 59
ES - Italia 56
CA - Canada 55
TG - Togo 47
JP - Giappone 43
MX - Messico 43
NG - Nigeria 42
AU - Australia 41
BJ - Benin 40
PL - Polonia 34
AR - Argentina 32
ZA - Sudafrica 27
AT - Austria 25
IQ - Iraq 20
EC - Ecuador 19
SA - Arabia Saudita 18
IR - Iran 17
MY - Malesia 17
CH - Svizzera 15
CL - Cile 15
UA - Ucraina 15
PK - Pakistan 12
PH - Filippine 11
CO - Colombia 10
DK - Danimarca 10
HR - Croazia 9
UZ - Uzbekistan 9
DZ - Algeria 8
TN - Tunisia 8
VE - Venezuela 8
BE - Belgio 7
JO - Giordania 7
NP - Nepal 7
PT - Portogallo 7
RO - Romania 7
UY - Uruguay 7
EG - Egitto 6
GR - Grecia 6
MA - Marocco 6
AL - Albania 5
AZ - Azerbaigian 5
HU - Ungheria 5
IL - Israele 5
IS - Islanda 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
KE - Kenya 4
BH - Bahrain 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
GD - Grenada 3
GE - Georgia 3
GH - Ghana 3
HN - Honduras 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
Totale 11.487
Salva come PNG Salva come JPEG
Città #
Singapore 729
Moscow 631
Ashburn 602
Dallas 569
San Jose 530
Hong Kong 285
Chandler 267
Council Bluffs 188
Verona 184
Dublin 152
The Dalles 122
Munich 114
New York 111
Ho Chi Minh City 104
Beijing 99
Los Angeles 92
Helsinki 77
Milan 73
London 66
Hanoi 65
Rome 52
Jakarta 51
Lappeenranta 51
Lomé 47
Buffalo 40
Cotonou 40
Southend 39
Redondo Beach 37
São Paulo 37
Naples 35
Lawrence 34
Princeton 34
Santa Clara 34
Abuja 33
Houston 31
Amsterdam 28
Bologna 28
Chicago 28
Seattle 28
Tokyo 28
Washington 28
Warsaw 27
Jacksonville 25
Sindelfingen 25
Wilmington 25
Frankfurt am Main 23
Orem 23
Chennai 22
Nuremberg 21
Phoenix 21
Venice 20
Mexico City 19
Atlanta 18
Brooklyn 18
Montreal 18
Istanbul 17
Madrid 16
Sydney 16
Florence 15
Johannesburg 14
Kuala Lumpur 14
Tianjin 14
Boston 13
Mumbai 13
Toronto 13
Xi'an 13
Barcelona 12
Enfield 12
Guangzhou 12
Rio de Janeiro 12
Shanghai 12
Turin 12
Belo Horizonte 11
Brasília 11
Baghdad 10
Columbus 10
Haiphong 10
Manchester 10
Palermo 10
Perth 10
Copenhagen 9
Da Nang 9
Denver 9
Dongguan 9
Esslingen am Neckar 9
Genoa 9
Santiago 9
Tashkent 9
Trieste 9
Vienna 9
Jinan 8
Mersin 8
Stockholm 8
Vicenza 8
Ankara 7
Bari 7
Brescia 7
Curitiba 7
Falkenstein 7
Newark 7
Totale 6.604
Salva come PNG Salva come JPEG
Nome #
Il ruolo della vitamina D nella dermatite atopica 424
A systematic review of treatments for pityriasis lichenoides 339
Dietary supplements for lipedema 318
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study 262
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 187
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 176
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 172
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 169
Polymorphisms, diet and nutrigenomics 167
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 160
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 157
Impact of the COVID-19 pandemic on melanoma diagnosis 156
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 155
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 153
Main nutritional deficiencies 153
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 152
Amicrobial Pustulosis of the Folds: Report of Three New Cases 135
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 134
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 132
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 132
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 131
Adrenergic urticaria successfully treated with omalizumab 129
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 128
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 127
Coexistence of scleromyxedema and Sneddon syndrome 126
Clinical profile and co-infections of urethritis in males 126
Dermoscopic features of nevoid melanoma: a retrospective study 125
Pretibial Dystrophic Epidermolysis Bullosa Successfully Treated with Upadacitinib: A Case Report 123
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma 122
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis 122
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review 120
Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review 119
Price variability of TNF-α inhibitor biosimilars among European countries 119
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 116
BRAF-Mutated Melanoma Cell Lines Develop Distinct Molecular Signatures After Prolonged Exposure to AZ628 or Dabrafenib: Potential Benefits of the Antiretroviral Treatments Cabotegravir or Doravirine on BRAF-Inhibitor-Resistant Cells 114
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series 113
The transition from mild to moderate-to-severe chronic plaque psoriasis 113
Clinical‐epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 112
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 111
Sezary syndrome with large cell transformation and T-follicular helper phenotype 111
Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics 108
Managing the Patient with Psoriasis and Metabolic Comorbidities 104
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome 104
Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report 102
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 102
Consensus on the place in therapy of TNF-a inhibitors in the treatment of patients with chronic plaque psoriasis 101
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 101
Awareness of obesity among patients with psoriasis 100
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events 100
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus 100
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities 98
Predictors of subsequent primary melanoma: a case-control study 96
Dupilumab for recalcitrant Kimura disease 95
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 94
Upadacitinib in refractory cutaneous pseudolymphoma: A case report 94
Lamivudine, Doravirine, and Cabotegravir downregulate the expression of Human Endogenous Retroviruses (HERVs), inhibit cell growth, and reduce invasive capability in melanoma cell lines 93
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs 93
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study 91
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 89
Optimization of long-range PCR protocol to prepare filaggrin exon 3 libraries for PacBio long-read sequencing 88
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 88
Dietary supplements for the management of COVID-19 symptoms 87
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies 87
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission. 87
Generalized pustular psoriasis successfully treated with spesolimab: A case report 86
In vitro cell culture of amniotic fluid keratinocytes on amniotic membrane: the ideal tissue for repairing skin ulcers 85
Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis 85
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 84
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination 82
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the “Save Your Skin” Screening Campaign 82
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies 82
The Risk of COVID‐19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 82
Biosimilars for the Treatment of Moderate to Severe Chronic Plaque Psoriasis 81
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 80
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules 80
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience 79
Polyphenols and Lactobacillus reuteri in oral health 78
Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro 78
Monkeypox virus infection: what dermatologist needs to know? 75
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis 75
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists 73
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 72
Novel loss-of-function variants in filaggrin exon 3 in patients with severe atopic dermatitis 69
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 68
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report 66
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 66
X-linked genodermatoses from diagnosis to tailored therapy 64
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 63
Omics sciences and precision medicine in melanoma 61
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks 61
Neurothekeoma: a pediatric case report and literature review 61
Long-term follow-up of Zoon balanitis: a retrospective cohort study 59
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis 59
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 57
Psoriasis: talking points from recent clinical trials 57
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? 57
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 56
Scurvy as Presenting Sign of Anorexia Nervosa 54
Super Responder Profle Under Bimekizumab Treatment in Moderate‐to‐Severe Psoriasis: A Short Term Real‐Life Observation—IL PSO (Italian Landscape Psoriasis) 53
Corymbose Syphilis 50
Totale 11.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.253
article - articoli 44.253
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022224 12 27 4 12 31 12 15 16 11 12 17 55
2022/20231.126 38 72 63 144 63 203 15 53 210 157 78 30
2023/2024940 59 64 97 102 82 166 67 57 16 44 108 78
2024/20252.473 119 104 125 379 118 145 227 112 376 192 167 409
2025/20266.751 423 480 439 870 1.731 378 682 468 470 392 162 256
Totale 11.650